ReViVox (Delnova)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameReViVox (Delnova)
Drug Alias NameRevivox
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHyperhidrosisUrinary RetentionMigraine Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDelNova Healthcare Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDelNova Healthcare Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperhidrosisUrinary RetentionMigraine Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A